Log in to search using one of your social media accounts:

 

Effects of Superfine Sheep Wool in Infantile Eczema Effects of Superfine Sheep Wool in Infantile Eczema
It's generally recommended that wool be avoided by persons with eczema. But could superfine merino wool actually reduce the severity of pediatric mild-to-moderate atopic dermatitis?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Probiotics Mix May Curb Atopic Dermatitis Severity, Topical Steroid Use in Young People Probiotics Mix May Curb Atopic Dermatitis Severity, Topical Steroid Use in Young People
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Extended Breastfeeding May Cut Later Flexural Dermatitis Risk
But breastfeeding promotion not tied to measures of atopic eczema, asthma on questionnaire (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 15, 2017 Category: Respiratory Medicine Tags: Dermatology, Family Medicine, Nursing, Pediatrics, Pulmonology, Allergy, Journal, Source Type: news

Skin Absorption Through Atopic Dermatitis Skin Skin Absorption Through Atopic Dermatitis Skin
Do patients with atopic dermatitis have greater skin absorption than healthy controls? Are they at higher risk of systemic exposure to chemicals from topical products?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Medical News Today: What is dermatitis neglecta?
Dermatitis neglecta is a skin disorder caused by not cleaning the skin well or often enough. In this article, learn about diagnosis and prevention. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 3, 2017 Category: Consumer Health News Tags: Dermatology Source Type: news

Eczema Can Predict Severity of Asthma Hospitalization Eczema Can Predict Severity of Asthma Hospitalization
A family history of asthma and a patient's own history of atopic dermatitis are linked to a more severe hospital experience, according to a study that could influence care decisions.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 31, 2017 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

In atopic dermatitis, are you employing the therapeutic ladder approach?
(Source: Dermatology Times)
Source: Dermatology Times - October 30, 2017 Category: Dermatology Source Type: news

Atopic dermatitis: Biologics to watch in 2018
(Source: Dermatology Times)
Source: Dermatology Times - October 30, 2017 Category: Dermatology Source Type: news

New Drugs for Atopic Dermatitis Boost Treatment Options New Drugs for Atopic Dermatitis Boost Treatment Options
For decades there were few options for people with atopic dermatitis, but new choices, with more in the pipeline, have meant a substantial shift in treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

How olive oil skincare cleaned up eczema
Hannah Barnett, 32, from Sydney, thought she had tried everything for her debilitating eczema and dermatitis when she stumbled upon what she now believes has been 'life changing' for her skin. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2017 Category: Consumer Health News Source Type: news

Recommendations for systemic therapy in eczema
New recommendations from the International Eczema Council aim to address a question that has gone largely unanswered: When should dermatologists and others prescribe systemic therapy to treat atopic dermatitis? (Source: Dermatology Times)
Source: Dermatology Times - October 23, 2017 Category: Dermatology Source Type: news

Volatility in atopic dermatitis can impede treatment course
“Because atopic dermatitis is episodic, its incidence, prevalence, persistence, remission, flare and long-term control require careful definition,” researchers write. (Source: Dermatology Times)
Source: Dermatology Times - October 23, 2017 Category: Dermatology Source Type: news

Management of contact dermatitis
Dr Graham Johnston gives an overview of evidence-based recommendations for the management of contact dermatitis. (Source: GP Online Education)
Source: GP Online Education - October 18, 2017 Category: Primary Care Tags: Eczema Source Type: news

Eczema Phenotypes May Indicate Outcomes
(MedPage Today) -- Categorizing the development of atopic dermatitis in infants and toddlers (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - October 7, 2017 Category: Pediatrics Source Type: news

EC grants marketing authorisation for Sanofi and Regeneron ’s Dupixent for AD
The European Commission (EC) has granted marketing authorisation for Sanofi and Regeneron Pharmaceuticals ’ Dupixent (dupilumab) to treat adults with moderate to severe atopic dermatitis (AD), a form of eczema. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news

EU Approves Dupilumab (Dupixent) for Atopic Dermatitis EU Approves Dupilumab (Dupixent) for Atopic Dermatitis
The European Commission has granted marketing authorization to dupilumab for adults with moderate to severe atopic dermatitis, according to a company news release.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2017 Category: Consumer Health News Tags: Dermatology News Alert Source Type: news

Regeneron and Sanofi Announce Approval of DUPIXENT(R) (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union
First targeted biologic in the European Union to receive marketing authorization for use in atopic dermatitis TARRYTOWN, N.Y. and PARIS, Sept. 28, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sano... Biopharmaceuticals, Dermatology, Regulatory Regeneron Pharmaceuticals, Sanofi, DUPIXENT, dupilumab, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2017 Category: Pharmaceuticals Source Type: news

EU approves Sanofi and Regeneron's dupilumab in eczema
PARIS (Reuters) - The European Commission approved Regeneron Pharmaceuticals' and Sanofi's key biologic treatment dupilumab for moderate-to-severe atopic dermatitis, the two companies said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Atopic Eczema (Atopic Dermatitis) Quiz: Test Your Skin Disorders IQ
Title: Atopic Eczema (Atopic Dermatitis) Quiz: Test Your Skin Disorders IQCategory: MedicineNet QuizCreated: 3/20/2012 12:50:00 PMLast Editorial Review: 9/20/2017 12:22:53 PM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 20, 2017 Category: Dermatology Source Type: news

Sanofi and Regeneron report positive Phase III data from atopic dermatitis trial
Sanofi and Regeneron Pharmaceuticals have reported positive results from the Phase III clinical trial (CAF É ) of Dupixent (dupilumab) to treat moderate-to-severe atopic dermatitis (AD). (Source: Drug Development Technology)
Source: Drug Development Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news

Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial
Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Lilly/Incyte pill beats placebo in mid-stage eczema trial
(Reuters) - Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis. (Source: Reuters: Health)
Source: Reuters: Health - September 14, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

T.R.U.E. Test(R) Ready-To-Use Patch Test Receives FDA Approval For Pediatric Use
PHOENIX, Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- SmartPractice has received FDA approval for T.R.U.E. TEST (truetest.com) ready-to-use patch test panels for pediatric patients as young as 6 years of age. T.R.U.E. TEST is the only FDA-a... Diagnostics, Dermatology, FDA SmartPractice, T.R.U.E. TEST, allergic contact dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

What Proteins Cause Cow ’ s Milk Protein Allergy?
Discussion Cow’s milk protein allergy (CMPA) is one of the most common food allergies. It is estimated to have an incidence of 2-7.5% in infants and a prevalence of 0.5% in breastfeed infants. The prevalence decreases with age at 1% in children> or = 6 years. CMPA does not have a laboratory test and therefore is a clinical diagnosis. It is defined as a “hypersensitivity reaction brought on by specific immunologic mechanisms to cow’s milk.” Generally symptoms present within the first month of life and involve 2 of more systems with 2 or more symptoms. Systems are dermatologic (including atopic der...
Source: PediatricEducation.org - September 11, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Vitamin D, Dust Mites, and Atopic Dermatitis
(MedPage Today) -- Korean study suggests a connection (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 28, 2017 Category: Allergy & Immunology Source Type: news

Medical News Today: Seborrheic dermatitis: Natural treatments and remedies
Seborrheic dermatitis is a skin condition that frequently affects the scalp and upper body. Learn about causes, symptoms, and natural ways to treat it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 26, 2017 Category: Consumer Health News Tags: Dermatology Source Type: news

A Rare, Unforeseen Complication Of Facial Skin Resurfacing A Rare, Unforeseen Complication Of Facial Skin Resurfacing
Erosive pustular dermatitis (EPD), a rare condition that typically affects actinically damaged skin on the scalp, may also emerge on the face after cosmetic resurfacing, researchers have found.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 25, 2017 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

CME Outfitters Launches Two New Activities on Atopic Dermatitis
Two free CME Outfitters “Snacks” on the treatment and management of atopic dermatitis are now available to clinicians(PRWeb August 23, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14626378.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 23, 2017 Category: Pharmaceuticals Source Type: news

In-depth Assessment Should Precede Systemic Therapy for Atopic Dermatitis: Experts In-depth Assessment Should Precede Systemic Therapy for Atopic Dermatitis: Experts
Patients with severe signs and symptoms of atopic dermatitis should receive in-depth assessment before starting systemic medication, according to a new consensus statement from the International Eczema Council.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 22, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

MatriSys commences dosing in Phase IIa trial for atopic dermatitis
MatriSys Bioscience has started dosing patients with a lotion containing Staphylococcus hominis (S. hominis) in a Phase IIa clinical trial to treat adults with moderate-to-severe atopic dermatitis (AD). (Source: Drug Development Technology)
Source: Drug Development Technology - August 21, 2017 Category: Pharmaceuticals Source Type: news

Seborrheic Dermatitis
Title: Seborrheic DermatitisCategory: Diseases and ConditionsCreated: 3/16/2012 12:00:00 AMLast Editorial Review: 8/9/2017 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - August 9, 2017 Category: Dermatology Source Type: news

Medical News Today: Eczema could be treated with a pregnancy protein
A protein called HLA-G1, which protects the fetus against maternal immune system attack in pregnancy, may help to treat atopic dermatitis, study finds. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 7, 2017 Category: Consumer Health News Tags: Dermatology Source Type: news

Thermal injury caused by the explosion of a lithium-ion mobile phone battery - Corazza M, Forconi R, Musmeci D, Toni G, Borghi A.
Mobile phones are part of everyday life. They are generally considered safe for our health, but they may sometimes elicit contact dermatitis, especially due to metals. Furthermore they are under investigation for being involved in the development of defect... (Source: SafetyLit)
Source: SafetyLit - August 5, 2017 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Biomarkers in Contact Dermatitis Biomarkers in Contact Dermatitis
Could biomarkers help differentiate between irritant and allergic contact dermatitis?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 3, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Countering atopic dermatitis immune reactions
(Hokkaido University) A protein which protects the fetus during pregnancy, HLA-G1, shows high potential for treating atopic dermatitis and other related diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 3, 2017 Category: Infectious Diseases Source Type: news

Glenmark Pharma releases investigational skin findings
Glenmark Pharma President and Chief Medical Officer Fred Grossman said atopic dermatitis can have a severe impact on quality of life and there is an unmet need for durable therapies (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 1, 2017 Category: Pharmaceuticals Source Type: news

Glenmark ’s Phase IIa study of atopic dermatitis drug shows improved symptoms
Glenmark Pharmaceuticals has reported positive results from the Phase IIa clinical trial of its investigational candidate GBR 830 in patients with atopic dermatitis. (Source: Drug Development Technology)
Source: Drug Development Technology - July 31, 2017 Category: Pharmaceuticals Source Type: news

Atopic Dermatitis in Adults Tough Nut to Crack Atopic Dermatitis in Adults Tough Nut to Crack
Only half as many adults as children are affected by atopic dermatitis, but diagnosis is more complicated, and the condition may be underreported in this population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2017 Category: Consumer Health News Tags: Dermatology News Source Type: news

Eczema warning: Why you should never do this in the shower
ECZEMA - also called atopic dermatitis - affects six million people in the UK, and the condition causes the skin to become itchy, red, dry and cracked. However, popular bathroom products may be to blame. (Source: Daily Express - Health)
Source: Daily Express - Health - July 27, 2017 Category: Consumer Health News Source Type: news

New Therapies in the Spotlight at AAD Summer Meeting New Therapies in the Spotlight at AAD Summer Meeting
Agents that target interleukin-23 for atopic dermatitis and psoriasis will be among the hot topics presented at the upcoming American Academy of Dermatology (AAD) Summer Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2017 Category: Consumer Health News Tags: Dermatology News Source Type: news

EU Panel Recommends Dupilumab (Dupixent) for Eczema EU Panel Recommends Dupilumab (Dupixent) for Eczema
A committee of the European Medicines Agency has recommended marketing authorization for dupilumab (Dupixent) for the treatment of moderate to severe atopic dermatitis in adults who are candidates for systemic therapy.International Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 21, 2017 Category: Allergy & Immunology Tags: Dermatology News Alert Source Type: news

Non-Topical Management of Recalcitrant Atopic Dermatitis Non-Topical Management of Recalcitrant Atopic Dermatitis
What are the best ways to manage atopic dermatitis in children -- when other treatment strategies fail?Archives of Disease in Childhood (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Menlo Therapeutics Raises $50M
venBio leads Series C Financing of oral once-daily Anti-Pruritus Therapy in development for Pruritus of Atopic Dermatitis, Psoriasis and Prurigo Nodularis, and for Refractory Chronic Cough MENLO PARK, Calif., July 18, 2017 -- (Healthcare Sales & Marketi... Biopharmaceuticals, Venture Capital Menlo Therapeutics, Serlopitant, pruritus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 18, 2017 Category: Pharmaceuticals Source Type: news

Gene mutations suggest potential treatment strategy for severe eczema
Researchers identified symptom-causing mutations in people with severe atopic dermatitis, or eczema. The findings suggest a treatment strategy, and trials are being planned. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - July 11, 2017 Category: Consumer Health News Source Type: news

Diving into the depths of atopic dermatitis
(Source: ScienceNOW)
Source: ScienceNOW - July 6, 2017 Category: Science Authors: Pujanandez, L. Tags: twis Source Type: news

Psychological Risks Higher in Atopic Dermatitis Patients
However, this does not translate into increased use of health care services, suicide (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 1, 2017 Category: Psychiatry Tags: Dermatology, Family Medicine, Gynecology, Internal Medicine, Allergy, Nursing, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news

Large Study Finds No Link Between Eczema, Cardiovascular Disease Large Study Finds No Link Between Eczema, Cardiovascular Disease
Atopic dermatitis (AD) is unlikely to be associated with cardiovascular disease, new research shows.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 27, 2017 Category: Allergy & Immunology Tags: Pathology & Lab Medicine News Source Type: news

German man developed severe rash from eating raw mushrooms
A German man, 50, was diagnosed with flagellate dermatitis, a toxic reaction caused by eating shiitake mushrooms raw ­or undercooked. Only 100 cases have been reported worldwide. (Source: the Mail online | Health)
Source: the Mail online | Health - June 27, 2017 Category: Consumer Health News Source Type: news

Study Challenges Touted Link Between Eczema and Heart Disease
MONDAY, June 26, 2017 -- There's no evidence of a link between eczema and increased risk of heart disease, researchers report. The findings challenge recent studies suggesting that people with atopic dermatitis -- a common form of the skin disease... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 26, 2017 Category: General Medicine Source Type: news

Medical News Today: Contact dermatitis: Triggers and treatment
The unpleasant itching of contact dermatitis may be experienced by everyone once in their lifetime, but what is it? How can it be treated? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 26, 2017 Category: Consumer Health News Tags: Dermatology Source Type: news